Word

HEALOME

Status

Pending

Status Code

645

Status Date

Tuesday, July 9, 2024

Serial Number

79377294

Mark Type

4

Filing Date

Monday, February 27, 2023

Trademark Owner History

Healome Therapeutics Ltd

Classifications

5 Pharmaceutical preparations and substances for; pharmaceutical preparations, substances and treatments used for treatment for ocular diseases and conditions; pharmaceutical preparations, substances and treatment used for treatment for ocular diseases, ocular surface diseases and dry eye disease; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations, substances and treatment used for treatment for dermal diseases and conditions; pharmaceutical preparations, substances and treatment used for treatment for scar prevention, wound healing, medical aesthetics and orthopaedic conditions; therapeutic preparations and substances, namely, for the treatment of ocular diseases, ocular conditions, ocular surface diseases and dry eye disease; gels for ; therapeutic gels for ; gel and liquid drops, sprays, films for , suspensions, and substances for the treatment of ocular diseases and conditions; gels, suspensions in the nature of , and liquids for the treatment of ocular diseases and conditions; gels, suspensions, liquids and lubricants for the treatment of eye conditions and diseases; tear film substitutes for the treatment of ocular conditions; tear film substitutes for the treatment of eye conditions and diseases; gels, suspensions in the nature of , liquids and lubricants for the treatment of eye conditions, namely, glaucoma, cataracts, amblyopia, age-related macular degeneration and diabetes-related retinopathy; gels, suspensions, and liquids for medical and therapeutic use; eye drops; eye ointment; eye-washes; eye lotions for medical use; lubricating eye drops; liquid for the treatment of ocular diseases and conditions; ocular lubricants; tear film substitutes; tear substitutes for ocular diseases and conditions; tear film substitutes, namely, for ocular diseases and conditions

42 Scientific and technological services and research and design relating thereto, namely, ; industrial analysis and research services in the fields of ; product research and development services; scientific and technological services and research services relating thereto; scientific research services for medical, biomedical and therapeutic purposes in the fields of ; medical and bioscience research services in the fields of ; biomedical research services; surveying and exploration services; research and development services relating to ocular diseases, treatment and conditions; research and development services relating to orthopaedics; research and development services relating to dermatology; research and development services relating to dermal applications, such as scar prevention, wound healing, medical aesthetics; research and development services relating to the treatment of diseases and conditions; research services relating to the treatment of eye diseases and conditions; therapeutic research services; advisory, consultancy and information services relating to all the aforesaid

Trademark Events

Aug 24, 2023

Sn Assigned For Sect 66a Appl From Ib

Aug 25, 2023

New Application Office Supplied Data Entered

Aug 29, 2023

Application Filing Receipt Mailed

Oct 31, 2023

Teas Change Of Owner Address Received

Oct 31, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Oct 31, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Oct 31, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Oct 31, 2023

Teas Change Of Domestic Representatives Address

Oct 31, 2023

Teas Change Of Correspondence Received

Nov 28, 2023

Assigned To Examiner

Dec 4, 2023

Non-Final Action Written

Dec 5, 2023

Refusal Processed By Mpu

Jan 3, 2024

Refusal Processed By Ib

Jun 4, 2024

Teas/Email Correspondence Entered

Jun 4, 2024

Correspondence Received In Law Office

Jun 4, 2024

Teas Response To Office Action Received

Jul 9, 2024

Final Refusal Written

Jul 9, 2024

Final Refusal E-Mailed

Jul 9, 2024

Notification Of Final Refusal Emailed

Dec 8, 2023

Non-Final Action Mailed - Refusal Sent To Ib

Dec 5, 2023

Non-Final Action (Ib Refusal) Prepared For Review